Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 28, Issue Suppl 1
A prostagrandin E2 receptor subtype EP1 receptor antagonist reduces hyperalgesia and allodynia as well as morphine in CCI rats: 91.
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Posters: miscellaneous
A prostagrandin E2 receptor subtype EP1 receptor antagonist reduces hyperalgesia and allodynia as well as morphine in CCI rats: 91.
Online download statistics by month:
Online download statistics by month: May 2019 to September 2024
Abstract
Full
Pdf
May 2019
0
0
1
Mar 2022
0
0
1
Aug 2023
0
0
1
Aug 2024
0
0
1
Sep 2024
0
0
1
Total
0
0
5
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF